Top Buy
| Wertpapier | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 36 | 0 | 1 | 0 | 138,10 € | 236,30 € | 71,11 % |
| Neurocrine Bioscience | 31 | 0 | 4 | 0 | 122,80 € | 140,60 € | 14,50 % |
| Icon plc | 22 | 0 | 4 | 0 | 297,60 € | 324,79 € | 9,14 % |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 5 | 0 | 38,40 € | 84,74 € | 120,69 % |
| United Therapeutics | 20 | 0 | 2 | 0 | 255,70 € | 287,40 € | 12,40 % |
| Exelixis Inc. | 18 | 0 | 0 | 0 | 20,63 € | 26,01 € | 26,06 % |
| Insulet Corp. | 17 | 0 | 3 | 0 | 176,75 € | 216,46 € | 22,47 % |
| Merit Medical Systems | 17 | 0 | 0 | 0 | 76,50 € | 86,90 € | 13,59 % |
| Arrowhead Pharmaceuticals Inc. | 16 | 2 | 4 | 0 | 22,69 € | 54,74 € | 141,23 % |
| Halozyme Therapeutics Inc. | 16 | 0 | 3 | 0 | 47,29 € | 47,07 € | -0,46 % |
| PTC Therapeutics Inc. | 15 | 8 | 2 | 3 | 33,60 € | 41,51 € | 23,55 % |
| Amedisys Inc. | 14 | 0 | 0 | 0 | 83,00 € | 92,26 € | 11,16 % |
| Repligen Corp. | 13 | 0 | 0 | 0 | 135,50 € | 184,76 € | 36,35 % |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | 371,10 € | 419,64 € | 13,08 % |
| CONMED Corp. | 11 | 1 | 0 | 0 | 71,00 € | 106,18 € | 49,55 % |
| LivaNova plc | 10 | 0 | 1 | 0 | 54,50 € | 66,35 € | 21,75 % |
| Bio-Techne Corp. | 10 | 0 | 0 | 0 | 73,00 € | 75,94 € | 4,02 % |
| Xencor Inc. | 10 | 1 | 1 | 0 | 20,00 € | 32,58 € | 62,89 % |
| Ensign Group Inc. | 9 | 0 | 0 | 0 | 110,00 € | 118,72 € | 7,93 % |
| QIAGEN NV | 8 | 0 | 0 | 0 | 40,47 € | 47,44 € | 17,22 % |
| Masimo Corp. | 8 | 1 | 1 | 0 | 114,60 € | 147,56 € | 28,76 % |
| MorphoSys AG | 7 | 0 | 0 | 0 | 67,90 € | 65,00 € | -4,27 % |
| Gerresheimer AG | 7 | 0 | 1 | 0 | 108,40 € | 117,50 € | 8,39 % |